Sanofi is one of the world’s largest pharmaceutical companies and a global healthcare leader, delivering innovative therapeutic solutions for patients’ needs.
Well-known for their portfolio of insulin and insulin delivery devices, Sanofi was looking to expand into the blood glucose monitoring (BGM) market. After a comprehensive search, they selected AgaMatrix as their exclusive BGM partner.
This strategic, long-term partnership allows us to co-develop cutting-edge solutions in diabetes management featuring AgaMatrix’s patented WaveSense technology, ushering in the next generation of blood glucose monitors with intelligent features and integrated connectivity.
For more information about Sanofi products, visit: www.mystarsanofi.com.
In building our Global Diabetes Division, our objectives included conducting an exhaustive search for potential partners that have excellent core science, are highly innovative, and have the potential to develop a broad range of products. With AgaMatrix, we’ve found a company that can meet all three objectives in the BGM category.
– Eric Petreto (Vice President of Device Strategy, Sanofi-Aventis Global Diabetes Division)